Advisory Committee on the Food and Drug Administration : final report : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Second Congress, first session, on reviewing the Advisory Committee on the Food and Drug Administration report on the current state of FDA, and its recommendations to strengthen FDA, May 15, 1991.

User fees for the Food and Drug Administration : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Second session, on examining proposed legislation to authorize the Food and Drug Administration to charge user fees to prescription drug manufacturers to increase resources to improve the review time on drug applications, September 22, 1992.

United States. Congress. Senate. Committee on Labor and Human Resources.

January 1992

Shipping list no.: 94-0359-P.Distributed to some depository libraries in microfiche.Mode of access: ...

FDA and the medical device industry : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, March 25 and June 3, 1992.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 102-129."Shipping list no.: 92-0515-P.Distributed to some depository libraries in microf...

Medical devices : hearing before the Committee on Labor and Human Resources, United States Senate, One Hundred First Congress, second session, on examining proposed legislation to revise and strengthen the Food and Drug Administration's regulation of medical devices, July 25, 1990.

United States. Congress. Senate. Committee on Labor and Human Resources.

Shipping list no.: 91-209-P.Distributed to some depository libraries in microfiche.Includes bibliogr...

The FDA and the future of American biomedical and food industries : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, first session, on examining activities of the Food and Drug Afministration focusing on the challenges and opportunities facing the pharmaceutical, biotech, medical device, and food industries, and FDA's regulation of these industries, April 5 and 6, 1995.

United States. Congress. Senate. Committee on Labor and Human Resources.

January 1995

Shipping list no.: 95-0243-P.Distributed to some depository libraries in microfiche.Includes bibliog...

Consumer protection at the Food and Drug Administration : hearing before the Ad Hoc Subcommittee on Consumer and Environmental Affairs of the Committee on Governmental Affairs, United States Senate, One Hundred Second Congress, first session, September 27, 1991.

United States. Congress. Senate. Committee on Governmental Affairs. Ad Hoc Subcommittee on Consumer and Environmental Affairs.

January 1994

Shipping list no.: 94-0359-P.Distributed to some depository libraries in microfiche.Includes bibliog...

Revitalizing new product development from clinical trials through FDA review : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, second session, on S. 1477 ... February 21, 1996.

United States. Congress. Senate. Committee on Labor and Human Resources.

January 1996

Shipping list no.: 96-0240-P.Distributed to some depository libraries in microfiche.Includes bibliog...

FDA medical product approvals : hearing before the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 8, 1995.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs.

January 1997

Shipping list no.: 97-0171-P.Distributed to some depository libraries in microfiche.Mode of access: ...

FDA's drug and device review process : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 6, 1992.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 102-132."Shipping list no.: 92-0573-P.Distributed to some depository libraries in microf...

Food and Drug Administration management concerns : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, second session, April 1, 1998.

United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 105-75."Shipping list no.: 98-0248-P.Distributed to some depository libraries in microfi...

Council on Competitiveness and FDA plans to alter the drug approval process at FDA : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, second session, March 19, 1992.

United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee.

January 1993

Shipping list no.: 93-0181-P.Distributed to some depository libraries in microfiche.Includes bibliog...

Drugs and biologics : hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, May 25, 1995--a consumer's perspective, June 19, 1995--FDA review process.

United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 104-23."Shipping list no.: 95-0306-P.Distributed to some depository libraries in microfi...

FDA Export Reform and Enhancement Act of 1995 : hearing before the Subcommittee on Aging of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, first session on S. 593 ... July 13, 1995.

United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Aging.

January 1995

Shipping list no.: 96-0004-P.Distributed to some depository libraries in microfiche.Mode of access: ...

FDA Modernization Act : implementation of the law : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, first session on examining the Food and Drug Administration Modernization Act (P.L. 105-115), focusing on provisions on pharmaceuticals and medical devices, October 21, 1999.

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

January 2000

Shipping list no.: 2000-0166-P.Distributed to some depository libraries in microfiche.Microfiche.Mod...

Food safety : oversight of the FDA Center for Veterinary Medicine : hearing before the Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, second session, May 10, 1996.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations.

January 1997

Shipping list no.: 97-0002-P.Distributed to some depository libraries in microfiche.Mode of access: ...

FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [sic] meets standards for safety and efficacy, March 1, 2005.

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

January 2005

Distributed to some depository libraries in microfiche.Shipping list no.: 2005-0226-P."Printed for t...

User fees for the Food and Drug Administration : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Second session, on examining proposed legislation to authorize the Food and Drug Administration to charge user fees to prescription drug manufacturers to increase resources to improve the review time on drug applications, September 22, 1992.

United States. Congress. Senate. Committee on Labor and Human Resources.

January 1992

Shipping list no.: 94-0359-P.Distributed to some depository libraries in microfiche.Mode of access: ...

FDA and the medical device industry : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, March 25 and June 3, 1992.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 102-129."Shipping list no.: 92-0515-P.Distributed to some depository libraries in microf...

Medical devices : hearing before the Committee on Labor and Human Resources, United States Senate, One Hundred First Congress, second session, on examining proposed legislation to revise and strengthen the Food and Drug Administration's regulation of medical devices, July 25, 1990.

United States. Congress. Senate. Committee on Labor and Human Resources.

Shipping list no.: 91-209-P.Distributed to some depository libraries in microfiche.Includes bibliogr...

The FDA and the future of American biomedical and food industries : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, first session, on examining activities of the Food and Drug Afministration focusing on the challenges and opportunities facing the pharmaceutical, biotech, medical device, and food industries, and FDA's regulation of these industries, April 5 and 6, 1995.

United States. Congress. Senate. Committee on Labor and Human Resources.

January 1995

Shipping list no.: 95-0243-P.Distributed to some depository libraries in microfiche.Includes bibliog...

Consumer protection at the Food and Drug Administration : hearing before the Ad Hoc Subcommittee on Consumer and Environmental Affairs of the Committee on Governmental Affairs, United States Senate, One Hundred Second Congress, first session, September 27, 1991.

United States. Congress. Senate. Committee on Governmental Affairs. Ad Hoc Subcommittee on Consumer and Environmental Affairs.

January 1994

Shipping list no.: 94-0359-P.Distributed to some depository libraries in microfiche.Includes bibliog...

Revitalizing new product development from clinical trials through FDA review : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, second session, on S. 1477 ... February 21, 1996.

United States. Congress. Senate. Committee on Labor and Human Resources.

January 1996

Shipping list no.: 96-0240-P.Distributed to some depository libraries in microfiche.Includes bibliog...

FDA medical product approvals : hearing before the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 8, 1995.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs.

January 1997

Shipping list no.: 97-0171-P.Distributed to some depository libraries in microfiche.Mode of access: ...

FDA's drug and device review process : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 6, 1992.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 102-132."Shipping list no.: 92-0573-P.Distributed to some depository libraries in microf...

Food and Drug Administration management concerns : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, second session, April 1, 1998.

United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 105-75."Shipping list no.: 98-0248-P.Distributed to some depository libraries in microfi...

Council on Competitiveness and FDA plans to alter the drug approval process at FDA : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, second session, March 19, 1992.

United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee.

January 1993

Shipping list no.: 93-0181-P.Distributed to some depository libraries in microfiche.Includes bibliog...

Drugs and biologics : hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, May 25, 1995--a consumer's perspective, June 19, 1995--FDA review process.

United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 104-23."Shipping list no.: 95-0306-P.Distributed to some depository libraries in microfi...

FDA Export Reform and Enhancement Act of 1995 : hearing before the Subcommittee on Aging of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, first session on S. 593 ... July 13, 1995.

United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Aging.

January 1995

Shipping list no.: 96-0004-P.Distributed to some depository libraries in microfiche.Mode of access: ...

FDA Modernization Act : implementation of the law : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, first session on examining the Food and Drug Administration Modernization Act (P.L. 105-115), focusing on provisions on pharmaceuticals and medical devices, October 21, 1999.

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

January 2000

Shipping list no.: 2000-0166-P.Distributed to some depository libraries in microfiche.Microfiche.Mod...

Food safety : oversight of the FDA Center for Veterinary Medicine : hearing before the Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, second session, May 10, 1996.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations.

January 1997

Shipping list no.: 97-0002-P.Distributed to some depository libraries in microfiche.Mode of access: ...

FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [sic] meets standards for safety and efficacy, March 1, 2005.

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

January 2005

Distributed to some depository libraries in microfiche.Shipping list no.: 2005-0226-P."Printed for t...

User fees for the Food and Drug Administration : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Second session, on examining proposed legislation to authorize the Food and Drug Administration to charge user fees to prescription drug manufacturers to increase resources to improve the review time on drug applications, September 22, 1992.

United States. Congress. Senate. Committee on Labor and Human Resources.

January 1992

Shipping list no.: 94-0359-P.Distributed to some depository libraries in microfiche.Mode of access: ...

FDA and the medical device industry : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, March 25 and June 3, 1992.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 102-129."Shipping list no.: 92-0515-P.Distributed to some depository libraries in microf...

Medical devices : hearing before the Committee on Labor and Human Resources, United States Senate, One Hundred First Congress, second session, on examining proposed legislation to revise and strengthen the Food and Drug Administration's regulation of medical devices, July 25, 1990.

United States. Congress. Senate. Committee on Labor and Human Resources.

Shipping list no.: 91-209-P.Distributed to some depository libraries in microfiche.Includes bibliogr...

Abstract

Extracted data

Abstract

Extracted data

Related items

Related items